The involvement of oxidative stress in epilepsy

Handbook of Free Radicals: Formation, Types and Effects

Volumn , Issue , 2010, Pages 305-318

  Hayashi, Masaharu ^a   Tanuma, Naoyuki ^a   Miyata, Rie ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953208738     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (42)

1. Hayashi, M. Role of oxidative stress in xeroderma pigmentosum. In: S. I. Ahmad, & F. Hanaoka (Eds.), Molecular mechanisms of xeroderma pigmentosum. Austin: Landes Bioscience, 2008, 120-127.
2. Allen, BW; Demchenko, IT; Piantadosi, CA. Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity. Journal of Applied Physiology, 2009, 106, 662-667.
3. Willcox, JK; Ash, SL; Catignani, GL. Antioxidants and Prevention of Chronic Disease. Critical Reviews in Food Science and Nutrition, 2004, 44, 275-295.
4. Trushima, E; McMurray, CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience, 2007, 145, 1233-1248.
5. Hayashi, M. Oxidative stress in developmental brain disorders. Neuropathology, 2009, 29, 1-8.
6. Halliwell, B. Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry, 2006, 97, 1634-1658.
7. Hayashi, M; Arai, N; Satoh, J; Suzuki, H; Katayama, K; Tamagawa, K; Morimatsu, Y. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. Journal of Child Neurology, 2002, 17, 725-730.
8. Hayashi, M; Araki, S; Arai, N; Kumada, S; Itoh, M; Tamagawa, K; Oda, M; Morimatsu, Y. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy. Brain and Development, 2002, 24, 770-775.
9. Hamano, K; Hayashi, M; Shioda, K; Fukatsu, R; Mizutani, S. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathologica, 2008, 115, 547-559.
10. Patel, M; Li, QY. Age dependence of seizure-induced oxidative stress. Neuroscience, 2003, 118, 431-437.
11. Sudha, K; Rao, AV; Rao, A. Oxidative stress and antioxidants in epilepsy. Clinica Chimica Acta; International Journal of Clinical Chemistry, 2001, 303, 19-24.
12. Lopez, J; Gonzalez, ME; Lorigados, L; Morales, L; Riveron, G; Bauza, JY. Oxidative stress markers in surgically treated patients with refractory epilepsy. Clinical Biochemistry, 2007, 40, 292-298.
13. Akarsu, S; Yilmaz, S; Ozan, S; Kurt, A; Benzer, F; Gurgoze, MK. Effects of febrile and afebrile seizures on oxidant state in children. Pediatric Neurology, 2007, 36, 307-311.
14. Kawakami, Y; Monobe, M; Kuwabara, K; Fujita, T; Maeda, M; Fujino, O; Kojima, S; Fukunaga, Y. A comparative study of nitric oxide, glutathione, and glutathione peroxidase activities in cerebrospinal fluid from children with convulsive diseases/children with aseptic meningitis. Brain and Development, 2006, 28, 243-246.
15. Michoulas, A; Tong, V; Teng, XW; Chang, TK; Abbott, FS; Farrell, K. Oxidative stress in children receiving valproic acid. Journal of Pediatrics, 2006, 149, 692-696.
16. Shulpis, KH; Lazaropoulou, C; Reqoutas, S; Karikas, GA; Marqeli, A; Tsakiris, S; Papassotiriou, I. Valproic acid monotherapy induces DNA oxidative damage. Toxicology, 2006, 217, 228-232.
17. Ben-Manachem, E; Kyllerman, M; Marklund, S. (2000) Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Research, 2000, 40, 33-39.
18. Hayashi, M; Araki, S; Kohyama, J; Shioda, K; Fukatsu, R. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain and Development, 2005, 27, 34-38.
19. Tanuma, N; Miyata, R; Hayashi, M; Uchiyama, A; Kurata, K. Oxidative stress as a biomarker of respiratory disturbance in patients with severe motor and intellectual disabilities. Brain and Development, 2008, 30, 402-409.
20. Shahwan A; Farrell M; Delanty, N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurology, 2005, 4, 239-248.
21. Haltia, M. The neuronal ceroid-lipofuscinosis. Biochimica et Biophysica Acta, 2006, 1762, 850-856.
22. Hachiya, Y; Hayashi, M; Kumada, S; Uchiyama, A; Tsuchiya, K; Kurata, K. Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses. Acta Neuropathologica, 2006, 111, 168-177.
23. Anzai, Y; Hayashi, M; Fueki, N; Kurata, K; Ohya, T. Protracted juvenile neuronal ceroid lipofuscinosis - an autopsy report and immunohistochemical analysis. Brain and Development, 2006, 28, 462-465.
24. Yamada, M; Tsuji, S; Takahashi, H. Genotype-phenotype correlation in CAG-repeat disease. Neuropathology, 2002, 22, 317-322.
25. Yamada, M; Wood, JD; Shimohata, T; Hayashi, S; Tsuji, S; Ross, CA. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Annals of Neurology, 2001, 49, 14-23.
26. Miyata, R; Hayashi, M; Tanuma, N; Shioda, K; Fukatsu, R; Mizutani, S. Oxidative stress in neurodegeneration in dentatorubral-pallidoluysian atrophy. Journal Neurological Science, 2008, 264, 133-139.
27. Puranam, KL; Wu, G; Strittmatter, WJ; Burke, JR. Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria. Biochemical and Biophysical Research Communications, 2006, 341, 607-613.
28. Firdaus, WJ; Wyttenbach, A; Giuliano, P; Kretz-Remy, C; Currie, RW; Arrigo AP. Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS Journal, 2006, 273, 5428-5441.
29. Lohi, H; Turnbull, J; Zhao, XC; Pullenayegum, S; Ianzano, L; Yahyaoui, M; Mikati, MA; Franceschetti, S; Zara, F; Minassian BA. Genetic diagnosis in Lafora disease. Genotype-phenotype correlations and diagnostic pitfalls. Neurology, 2007, 68, 996-1001.
30. Dulac, O; Tuxhorn, I. Infantile spasms and West syndrome. In: Roger, J; Bureau, M; Dravet, CH; Genton, P; Tassinari, CA; Wolf, P, editors. Epileptic syndrome in infancy, childhood and adolescence. 4th ed. Montrouge; John Libbey Eurotext, 2005, 53-72.
31. Tsuji, T; Okumura, A; Ozawa, H; Ito, M; Watanabe, K. Current treatment of West syndrome in Japan. Journal of Child Neurology, 2007, 22, 560-564.
32. Hayashi, M. Neuropathology of the limbic system and brainstem in West syndrome. Brain and Development, 2001, 23, 516-522.
33. Kohyama, J. Polysomnographical assessment of pathophysiology of West syndrome. Brain and Development, 2001, 23, 523-527.
34. Sadleir, LG; Scheffer, IE. Febrile seizures. British Medical Journal, 2007, 334, 307-311.
35. Farina, L; Bergqvist, C; Zimmerman, RA; Haselgrove, J; Hunter, JV; Bilaniuk, LT. Acute diffusion abnormalities in the hippocampus of children with new-onset seizures: the development of mesial temporal sclerosis. Neuroradiology, 2004, 46, 251-257.
36. Bernard, G; Shevell, MI. Channelopathies: a review. Pediatric Neurology, 2008, 38, 73-85.
37. Helbig, I; Scheffer, IE; Mulley, JC; Barkovic, SF. Navigating the channels and beyond: unraveling the genetics of the epilepsies. Lancet Neurology, 2008, 7, 231-245.
38. Shiihara, T; Kato, M; Ichiyama, T; Takahashi, Y; Tanuma, N; Miyata, R; Hayasaka, K. Acute encephalopathy with refractory status epilepticus: bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage. Journal of the Neurological Science, 2006, 250, 159-161.
39. Dube, CM; Brewster, AL; Baram, TZ. Febrile seizures: Mechanisms and relationship to epilepsy. Brain and Development, 2009, 31, 366-371.
40. Fujikawa, DG; Itabashi, HH; Wu, A; Shinmei SS. Status epilepticus - induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia, 2000, 41, 981-991.
41. Eid, T; Williamson, A; Lee, TW; Petroff, OA; de Lanerolle, NC. Glutamate and astrocytes - key players in human mesial temporal lobe epilepsy? Epilepsia, 2008, 49(Suppl. 2), 42-52.
42. Fukuda, F; Yamauchi, H; Yamamoto, H; Aminaka, M; Murakami, H; Kamiyama, N; Miyamoto, Y; Koitabashi, Y. The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels. Brain and Development, 2008, 30, 131-136.